Omega-3 multiple effects increasing glucocorticoid-induced muscle atrophy: autophagic, AMPK and UPS mechanisms

Imagem de Miniatura
Arquivos
art_FAPPI_Omega3_multiple_effects_increasing_glucocorticoidinduced_muscle_atrophy_autophagic_2019.PDF (5.57 MB)
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
KAWASAKI, Karine A.
BACELAR, Luana
Citação
PHYSIOLOGICAL REPORTS, v.7, n.1, article ID e13966, 18p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Muscle atrophy occurs in many conditions, including use of glucocorticoids. N-3 (omega-3) is widely consumed due its healthy properties; however, concomitant use with glucocorticoids can increase its side effects. We evaluated the influences of N-3 on glucocorticoid atrophy considering IGF-1, Myostatin, MEK/ERK, AMPK pathways besides the ubiquitin-proteasome system (UPS) and autophagic/lysosomal systems. Sixty animals constituted six groups: CT, N-3 (EPA 100 mg/kg/day for 40 days), DEXA 1.25 (DEXA 1.25 mg/kg/day for 10 days), DEXA 1.25 + N3 (EPA for 40 days + DEXA 1.25 mg/kg/day for the last 10 days), DEXA 2.5 (DEXA 2.5 mg/kg/day for 10 days), and DEXA 2.5 + N3 (EPA for 40 days + DEXA 2.5 mg/kg/day for 10 days). Results: N-3 associated with DEXA increases atrophy (fibers 1 and 2A), FOXO3a, P-SMAD2/3, Atrogin-1/MAFbx (mRNA) expression, and autophagic protein markers (LC3II, LC3II/LC3I, LAMP-1 and acid phosphatase). Additionally, N-3 supplementation alone decreased P-FOXO3a, PGC1-alpha, and type 1 muscle fiber area. Conclusion: N-3 supplementation increases muscle atrophy caused by DEXA in an autophagic, AMPK and UPS process.
Palavras-chave
autophagy, eicosapentaenoic acid, glucocorticoid, IGF-1 pathway, MEK/ERK pathway, muscle atrophy, Myostatin/Smad2/3 pathway, omega-3 fatty acid
URI
https://observatorio.fm.usp.br/handle/OPI/30864
Referências
  1. Andersson A, 2002, AM J CLIN NUTR, V76, P1222
  2. Aversa Z, 2012, BIOCHEM BIOPH RES CO, V423, P739, DOI 10.1016/j.bbrc.2012.06.029
  3. Bak DH, 2015, SCI REP-UK, V5, DOI 10.1038/srep15465
  4. Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
  5. Boonyarom O, 2006, ACTA PHYSIOL, V188, P77, DOI 10.1111/j.1748-1716.2006.01613.x
  6. Braun T. P., 2015, FRONT PHYSIOL, V6, DOI [10.3389/fphys.2015.00012, DOI 10.3389/FPHYS.2015.00012]
  7. Britto FA, 2014, AM J PHYSIOL-ENDOC M, V307, pE983, DOI 10.1152/ajpendo.00234.2014
  8. Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6
  9. Chen WY, 2012, J NUTR BIOCHEM, V23, P252, DOI 10.1016/j.jnutbio.2010.11.022
  10. Daviglus ML, 1997, NEW ENGL J MED, V336, P1046, DOI 10.1056/NEJM199704103361502
  11. Fappi A, 2014, BIOMED RES INT, DOI 10.1155/2014/961438
  12. Gao B, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.144
  13. Giron MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117520
  14. Glass DJ, 2003, TRENDS MOL MED, V9, P344, DOI 10.1016/S1471-4914(03)00138-2
  15. Gupta Anu, 2013, Indian J Endocrinol Metab, V17, P913, DOI 10.4103/2230-8210.117215
  16. Gwon DH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102081
  17. Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002
  18. Hess TM, 2012, J ANIM SCI, V90, P3023, DOI 10.2527/jas.2011-4412
  19. Hu SW, 2014, J BIOSCI BIOENG, V117, P457, DOI 10.1016/j.jbiosc.2013.09.005
  20. Hudson MB, 2014, AM J PHYSIOL-CELL PH, V307, pC314, DOI 10.1152/ajpcell.00395.2013
  21. Inoue T, 2017, BBA-MOL CELL BIOL L, V1862, P552, DOI 10.1016/j.bbalip.2017.02.010
  22. Jeng JY, 2009, J AGR FOOD CHEM, V57, P11455, DOI 10.1021/jf902021h
  23. Jesinkey SR, 2014, J PHARMACOL EXP THER, V351, P663, DOI 10.1124/jpet.114.217380
  24. Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442
  25. Khal J, 2008, BIOCHEM BIOPH RES CO, V375, P238, DOI 10.1016/j.bbrc.2008.08.004
  26. Kim S, 2018, ONCOL REP, V39, P239, DOI 10.3892/or.2017.6101
  27. Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289
  28. Koskela A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050284
  29. Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
  30. Lee Mak-Soon, 2016, Prev Nutr Food Sci, V21, P317, DOI 10.3746/pnf.2016.21.4.317
  31. Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
  32. Liu YL, 2013, J NUTR, V143, P1331, DOI 10.3945/jn.113.176255
  33. LIVINGSTONE I, 1981, NEUROPATH APPL NEURO, V7, P381, DOI 10.1111/j.1365-2990.1981.tb00240.x
  34. Ljubicic V, 2011, HUM MOL GENET, V20, P3478, DOI 10.1093/hmg/ddr265
  35. Long YC, 2011, MOL CELL BIOL, V31, P430, DOI 10.1128/MCB.00983-10
  36. Martins AR, 2018, J NUTR BIOCHEM, V55, P76, DOI 10.1016/j.jnutbio.2017.11.012
  37. Marzuca-Nassr GN, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12958
  38. Matsakas A, 2009, HISTOL HISTOPATHOL, V24, P611, DOI 10.14670/HH-24.611
  39. Menezes LG, 2007, J APPL PHYSIOL, V102, P698, DOI 10.1152/japplphysiol.01188.2005
  40. Muldoon MF, 2010, J NUTR, V140, P848, DOI 10.3945/jn.109.119578
  41. Nader GA, 2005, INT J BIOCHEM CELL B, V37, P1985, DOI 10.1016/j.biocel.2005.02.026
  42. National Institutes of Health, 2018, N OM 3 FATT AC FACT
  43. Nicolaides NC, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-71
  44. Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002
  45. Nishida H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128805
  46. OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613
  47. Peng YQ, 2012, MOL CELL BIOCHEM, V367, P165, DOI 10.1007/s11010-012-1329-4
  48. Qin WP, 2010, BIOCHEM BIOPH RES CO, V403, P473, DOI 10.1016/j.bbrc.2010.11.061
  49. Pereira RMR, 2011, JOINT BONE SPINE, V78, P41, DOI 10.1016/j.jbspin.2010.02.025
  50. Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738
  51. Rossmeisl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038834
  52. Salto R, 2014, FEBS LETT, V588, P2246, DOI 10.1016/j.febslet.2014.05.004
  53. Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
  54. Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8
  55. Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036
  56. Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253
  57. Shen LL, 2017, J LIPID RES, V58, P1808, DOI 10.1194/jlr.M075879
  58. Su HM, 2010, J NUTR BIOCHEM, V21, P364, DOI 10.1016/j.jnutbio.2009.11.003
  59. Taouis M, 2002, AM J PHYSIOL-ENDOC M, V282, pE664, DOI 10.1152/ajpendo.00320.2001
  60. Tisdale MJ, 2007, CLIN NUTR, V26, P161, DOI 10.1016/j.clnu.2006.09.006
  61. Troncoso R, 2014, CELL CYCLE, V13, P2281, DOI 10.4161/cc.29272
  62. Tsuchida W, 2017, J CELL PHYSIOL, V232, P650, DOI 10.1002/jcp.25609
  63. Vannice G, 2014, J ACAD NUTR DIET, V114, P136, DOI 10.1016/j.jand.2013.11.001
  64. Ventro GJ, 2017, J PEDIATR SURG, V52, P1020, DOI 10.1016/j.jpedsurg.2017.03.031
  65. Voisin L, 1996, J CLIN INVEST, V97, P1610, DOI 10.1172/JCI118586
  66. Wang C, 2014, INT J MOL SCI, V15, P15412, DOI 10.3390/ijms150915412
  67. Wang RX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156225
  68. Whitehouse AS, 2001, CANCER RES, V61, P3604
  69. Wu Y, 2010, ENDOCRINOLOGY, V151, P1050, DOI 10.1210/en.2009-0530
  70. Yao QH, 2015, ONCOL LETT, V9, P2736, DOI 10.3892/ol.2015.3110
  71. You JS, 2010, APPL PHYSIOL NUTR ME, V35, P310, DOI 10.1139/H10-022
  72. Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480

Coleções
Artigos e Materiais de Revistas Científicas - FM/MNE
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/15
Artigos e Materiais de Revistas Científicas - LIM/45